Skip to main content

Table 3 ICER of unrelated HSCT compared to BT-ICT, classified by patient age

From: A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand

Age (year)

Incremental cost

Incremental QALY

ICER of unrelated HSCT

compared to BT-ICT

 

million THB

QALY gained

THB per QALY gained*

1

0.96

4.57

209,000

5

0.94

4.16

225,000

10

0.91

3.05

297,000

15

0.84

0.87

953,000

17

0.80

0.26

3,270,000

18

0.78

-0.01

Dominated§

19

0.73

-0.57

Dominated§

20

0.68

-1.12

Dominated§

25

0.59

-2.28

Dominated§

28

0.60

-2.22

Dominated§

  1. ICER: incremental cost-effectiveness ratio; HSCT: hematopoietic stem cell transplantation; BT-ICT: blood transfusion combined with subcutaneous iron chelating therapy; THB: Thai baht (in 2008 value); and QALY: quality adjusted life year.
  2. *ICERs are rounded up to nearest 1,000 THB.
  3. §Negative ICER due to higher effectiveness and lower costs of BT-ICT compared with HSCT.